Efficacy and safety of cisplatin, dexamethasone, gemcitabine and pegaspargase (DDGP) regimen in newly diagnosed, advanced-stage extranodal natural killer/T-cell lymphoma: interim analysis of a phase 4 study NCT01501149

To explore a more effective treatment for newly diagnosed, advanced-stage extranodal natural killer/T-cell lymphoma, nasal type (ENKTL), we conducted a phase 4 study of the cisplatin, dexamethasone, gemcitabine, pegaspargase (DDGP) regimen. The primary end point was the 2-year progression-free survi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lei, Jia, Sisi, Ma, Yangyang, Li, Ling, Li, Xin, Wang, Xinhua, Fu, Xiaorui, Ma, Wang, Qin, Yanru, Li, Wencai, Wu, Jingjing, Sun, Zhenchang, Zhang, Xudong, Nan, Feifei, Chang, Yu, Li, Zhaoming, Zhang, Dandan, Wang, Guannan, Yan, Jiaqin, Su, Liping, Wang, Jinghua, Xue, Hongwei, Young, Ken H., Zhang, Mingzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342448/
https://www.ncbi.nlm.nih.gov/pubmed/27384676
http://dx.doi.org/10.18632/oncotarget.10124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342448/
https://www.ncbi.nlm.nih.gov/pubmed/27384676
http://dx.doi.org/10.18632/oncotarget.10124

Ejemplares similares